|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2008-4-10
|
|
pubmed:abstractText |
To estimate the prevalence of transmitted antiretroviral (ARV) drug resistance, and to assess whether resistance testing influences first-line ARV regimen selection.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1464-2662
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
285-93
|
|
pubmed:meshHeading |
pubmed-meshheading:18400075-Adult,
pubmed-meshheading:18400075-Clinical Protocols,
pubmed-meshheading:18400075-Cross-Sectional Studies,
pubmed-meshheading:18400075-Drug Administration Schedule,
pubmed-meshheading:18400075-Drug Resistance, Viral,
pubmed-meshheading:18400075-Female,
pubmed-meshheading:18400075-Genotype,
pubmed-meshheading:18400075-HIV Infections,
pubmed-meshheading:18400075-HIV Protease,
pubmed-meshheading:18400075-HIV-1,
pubmed-meshheading:18400075-Humans,
pubmed-meshheading:18400075-Male,
pubmed-meshheading:18400075-Prevalence,
pubmed-meshheading:18400075-Protease Inhibitors,
pubmed-meshheading:18400075-Questionnaires,
pubmed-meshheading:18400075-Reverse Transcriptase Inhibitors,
pubmed-meshheading:18400075-Treatment Failure
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
The prevalence of transmitted antiretroviral drug resistance in treatment-naïve patients and factors influencing first-line treatment regimen selection.
|
|
pubmed:affiliation |
Outcomes Research and Management, Merck & Co. Inc., West Point, PA 19446, USA. han-yao_huang@merck.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
